banner
IKK/IκB inhibitor Bardoxolone, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ754

IKK/IκB inhibitor Bardoxolone, Purity ≥98%

Synonym: Bardoxolone; CDDO; 218600-44-3; RTA 401; RTA-401; (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-Cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylic acid; 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid; IKK/IκB inhibitor

  • MDL: MFCD07772296
  • CAS Number: 218600-44-3
  • Compound CID: 400010
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Bardoxolone, soluble in DMSO and insoluble in ethanol and water, modulates IKK-IκB signaling pathway, which plays a key role in inflammation and immune responses.
Molecular Weight
491.66
Molecular Formula
C31H41NO4
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 5 mg/mL (10.17 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Bardoxolone can be utilized to study its effects on oxidative stress and inflammation through Nrf2 pathway activation.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0